Loading...
Please wait, while we are loading the content...
Similar Documents
Interval cancers in breast cancer screening: comparison of stage and biological characteristics with screen-detected cancers or incident cancers in the absence of screening.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Caumo, Francesca Vecchiato, Francesca Strabbioli, Marzia Zorzi, Manuel Baracco, Susanna Ciatto, Stefano |
| Copyright Year | 2010 |
| Abstract | AIMS AND BACKGROUND To analyze stage distribution and biological features of interval cancers observed in Verona mammography screening compared to screen-detected cancers and "clinical" cancers occurring in the absence of screening, as provided by the Veneto Cancer Registry. METHODS AND STUDY DESIGN Screen-detected cancers were identified in the screening archives. Interval cancers and clinical cancers (occurring in women never screened or not yet invited) were identified through the local cancer registry. Studied variables were age, stage, pathological pT and pN category, histological grading, estrogen and progesterone receptor status, and proliferation index (Ki67). RESULTS We compared 95 interval cancers, 761 screen-detected cancers, and 1873 clinical cancer cases. Interval cancers had more aggressive features than screen-detected cancers, the difference being statistically significant for pT (P=106), pN (P = 0.0003), grading (P = 0.007), estrogen receptors (P = 0.0006), and progesterone receptors (P = 0.00005), but not for Ki67 (P = 0.18). The features of interval cancers were not more aggressive than those of clinical cancers for pT (P = 0.84), pN (P = 0.33), grading (P = 0.61), estrogen receptors (P = 0.48), and progesterone receptors (P = 0.69), and were better for Ki67 (P = 0.02). In contrast, screen-detected cancers showed significantly better features than clinical cancers, for all studied variables: pT (P = 10(-6)), pN (P = 10(-6)), grading (P = 10(-6)), estrogen receptors (P = 10(-5)), progesterone receptors (P = 10(-6)), and Ki67 (P = 10(-6)). CONCLUSIONS Our findings are consistent with the length biased sampling hypothesis of interval cancers having a faster growth rate and a less favorable presentation than screen-detected cancers. Compared to clinical cancers, interval cancers had similar features, whereas screen-detected cancers had definitely more favorable features. This finding suggests, rather than a faster growth rate for interval cancers, a slower growth rate for screen-detected cancers, which, together with diagnostic anticipation, may explain a certain degree of overdiagnosis. |
| Starting Page | 198 |
| Ending Page | 201 |
| Page Count | 4 |
| File Format | PDF HTM / HTML |
| PubMed reference number | 20572574 |
| Journal | Medline |
| Volume Number | 96 |
| Issue Number | 2 |
| Alternate Webpage(s) | http://vecchiosito.istitutotumori.mi.it/istituto/documenti/rivistatumori/2010_02/03-Caumo(198-201).pdf |
| Journal | Tumori |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
